Extended base pair complementarity between U1 snRNA and the 5′ splice site does not inhibit splicing in higher eukaryotes, but rather increases 5′ splice site recognition

Nucleic Acids Research

Volumn 33, Issue 16, 2005, Pages 5112-5119

  Freund, Marcel ^b   Hicks, Martin J ^a   Konermann, Carolin ^b   Otte, Marianne ^b   Hertel, Klemens J ^a   Schaal, Heiner ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; FUNGAL RNA; SMALL NUCLEAR RNA; MESSENGER RNA; RNA PRECURSOR; U1 SMALL NUCLEAR RNA;

5' UNTRANSLATED REGION; ARTICLE; BASE PAIRING; EUKARYOTE; EXON; GENE ACTIVATION; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RNA ANALYSIS; RNA DEGRADATION; RNA SEQUENCE; RNA SPLICING; RNA STABILITY; RNA SYNTHESIS; SACCHAROMYCES CEREVISIAE; SPLICEOSOME; CHEMISTRY; HELA CELL; METABOLISM;

EUKARYOTA; SACCHAROMYCES CEREVISIAE;

BASE PAIRING; EXONS; HELA CELLS; HUMANS; RNA PRECURSORS; RNA SPLICE SITES; RNA SPLICING; RNA STABILITY; RNA, MESSENGER; RNA, SMALL NUCLEAR;

EID: 25144471268     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gki824     Document Type: Article

References (53)

1. Krummheuer,J., Lenz,C., Kammler,S., Scheid,A. and Schaal,H. (2001) Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression. Virology, 285, 276-289.
2. Sureau,A., Gattoni,R., Dooghe,Y., Stevenin,J. and Soret,J. (2001) SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs. EMBO J., 20, 1785-1796.
3. Seraphin,B. and Rosbash,M. (1989) Identification of functional U1 snRNA-pre-mRNA complexes committed to spliceosome assembly and splicing. Cell, 59, 349-358.
4. Xu,Y.Z., Newnham,C.M., Kameoka,S., Huang,T., Konarska,M.M. and Query,C.C. (2004) Prp5 bridges U1 and U2 snRNPs and enables stable U2 snRNP association with intron RNA. EMBO J., 23, 376-385.
5. Freund,M., Asang,C., Kammler,S., Konermann,C., Krummheuer,J., Hipp,M., Meyer,J., Gierling,W., Theiss,S., Preuss,T. et al. (2003) A novel approach to describe a U1 snRNA binding site. Nucleic Acids Res., 31, 6963-6975.
6. Staley,J.P. and Guthrie,C. (1998) Mechanical devices ofthe spliceosome: motors, clocks, springs, and things. Cell, 92, 315-326.
7. Madhani,H.D. and Guthrie,C. (1994) Dynamic RNA-RNA interactions in the spliceosome. Annu. Rev. Genet., 28, 1-26.
8. Luking,A., Stahl,U. and Schmidt,U. (1998) The protein family of RNA helicases. Crit. Rev. Biochem. Mol. Biol., 33, 259-296.
9. Staley,J.P. and Guthrie,C. (1999) An RNA switch at the 5′ splice site requires ATP and the DEAD box protein Prp28p. Mol. Cell, 3, 55-64.
10. Teigelkamp,S., Mundt,C., Achsel,T., Will,C.L. and Luhrmann,R. (1997) The human U5 snRNP-specific 100-kD protein is an RS domain-containing, putative RNA helicase with significant homology to the yeast splicing factor Prp28p. RNA, 3, 1313-1326.
11. Kammler,S., Leurs,C., Freund,M., Krummheuer,J., Seidel,K., Tange,T.O., Lund,M.K., Kjems,J., Scheid,A. and Schaal,H. (2001) The sequence complementarity between HIV-1 5′ splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA. RNA, 7, 421-434.
12. Staffa,A and Cochrane,A. (1994) The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3′ splice site. J. Virol., 68, 3071-3079.
13. O'Reilly,M.M., McNally,M.T. and Beemon,K.L. (1995) Two strong 5′ splice sites and competing, suboptimal 3′ splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology, 213, 373-385.
14. Lamond,A.I., Konarska,M.M. and Sharp,P.A. (1987) A mutational analysis of spliceosome assembly: Evidence for splice site collaboration during spliceosome formation. Genes Dev., 1, 532-543.
15. Staffa,A and Cochrane,A. (1995) Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol. Cell. Biol., 15, 4597-4605.
16. Si,Z.H., Rauch,D. and Stoltzfus,C.M. (1998) The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly. Mol. Cell. Biol., 18, 5404-5413.
17. Amendt,B.A., Si,Z.H. and Stoltzfus,C.M. (1995) Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: Evidence for inhibition mediated by cellular factors. Mol. Cell. Biol., 15, 4606-4615.
18. Tange,T.O. and Kjems,J. (2001) SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain. J. Mol. Biol., 312, 649-662.
19. Marchand,V., Mereau,A., Jacquenet,S., Thomas,D., Mougin,A., Gattoni,R., Stevenin,J. and Branlant,C. (2002) A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding. J. Mol. Biol., 323, 629-652.
20. Puig,O., Gottschalk,A., Fabrizio,P. and Seraphin,B. (1999) Interaction of the U1 snRNP with nonconserved intronic sequences affects 5′ splice site selection. Genes Dev., 13, 569-580.
21. Zhang,D. and Rosbash,M. (1999) Identification of eight proteins that cross-link to pre-mRNA in the yeast commitment complex. Genes Dev., 13, 581-592.
22. Del Gatto-Konczak,F., Bourgeois,C.F., Le Guiner,C., Kister,L., Gesnel,M.C., Stevenin,J. and Breathnach,R. (2000) The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5′ splice site. Mol. Cell. Biol., 20, 6287-6299.
23. Caputi,M., Freund,M., Kammler,S., Asang,C. and Schaal,H. (2004) A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression. J. Virol., 78, 6517-6526.
24. Schaal,H., Klein,M., Gehrmann,P., Adams,O. and Scheid,A. (1995) Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J. Virol., 69, 3308-3314.
25. Strebel,K., Daugherty,D., Clouse,K., Cohen,D., Folks,T. and Martin,M.A. (1987) The HIV 'A' (sor) gene product is essential for virus infectivity. Nature, 328, 728-730.
26. Schaal,H., Pfeiffer,P., Klein,M., Gehrmann,P. and Scheid,A. (1993) Use of DNA end joining activity of a Xenopus laevis egg extract for construction of deletions and expression vectors for HIV-1 Tat and Rev proteins. Gene, 124, 275-280.
27. Maddon,P.J., Dalgleish,A.G., McDougal,J.S., Clapham,P.R., Weiss,R.A. and Axel,R. (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell, 47, 333-348.
28. Selden,R.F., Howie,K.B., Rowe,M.E., Goodman,H.M. and Moore,D.D. (1986) Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol., 6, 3173-3179.
29. Laemmli,U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
30. Chomczynski,P. and Sacchi,N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
31. Lim,SR. and Hertel,K.J. (2004) Commitment to splice site pairing coincides with A complex formation. Mol. Cell, 15, 477-483.
32. Yeo,G. and Burge,C.B. (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol., 11, 377-394.
33. Roca,X., Sachidanandam,R. and Krainer,A.R. (2005) Determinants of the inherent strength of human 5′ splice sites. RNA, 11, 683-698.
34. Lund,M. and Kjems,J. (2002) Defining a 5′ splice site by functional selection in the presence and absence of U1 snRNA 5′ end. RNA, 8, 166-179.
35. Crispino,J.D., Blencowe,B.J. and Sharp,P.A. (1994) Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP. Science, 265, 1866-1869.
36. Crispino,J.D. and Sharp,P.A. (1995) A U6 snRNA:pRe-mRNA interaction can be rate-limiting for U1-independent splicing. Genes Dev., 9, 2314-2323.
37. Tarn,W.Y. and Steitz,J.A. (1994) SR proteins can compensate for the loss of U1 snRNP functions in vitro. Genes Dev., 8, 2704-2717.
38. Rossi,F., Forne,T., Antoine,E., Tazi,J., Brunel,C. and Cathala,G. (1996) Involvement of U1 small nuclear ribonucleoproteins (snRNP) in 5′ splice site-U1 snRNP interaction. J. Biol. Chem., 271, 23985-23991.
39. Wyatt,J.R., Sontheimer,E.J. and Steitz,J.A. (1992) Site-specific cross-linking of mammalian U5 snRNP to the 5′ splice site before the first step of pre-mRNA splicing. Genes Dev., 6, 2542-2553.
40. Teigelkamp,S., Whittaker,E. and Beggs,J.D. (1995) Interaction of the yeast splicing factor PRP8 with substrate RNA during both steps of splicing. Nucleic Acids Res., 23, 320-326.
41. Reyes,J.L., Gustafson,E.H., Luo,H.R., Moore,M.J. and Konarska,M.M. (1999) The C-terminal region of hPrp8 interacts with the conserved GU dinucleotide at the 5′ splice site. RNA, 5, 167-179.
42. Siatecka,M., Reyes,J.L. and Konarska,M.M. (1999) Functional interactions of Prp8 with both splice sites at the spliceosomal catalytic center. Genes Dev., 13, 1983-1993.
43. Collins,C.A. and Guthrie,C. (1999) Allele-specific genetic interactions between Prp8 and RNA active site residues suggest a function for Prp8 at the catalytic core of the spliceosome. Genes Dev., 13, 1970-1982.
44. Maroney,P.A., Romfo,C.M. and Nilsen,T.W. (2000) Functional recognition of 5′ splice site by U4/U6.U5 tri-snRNP defines a novel ATP-dependent step in early spliceosome assembly. Mol. Cell, 6, 317-328.
45. Zhuang,Y. and Weiner,A.M. (1986) A compensatory base change in U1 snRNA suppresses a 5′ splice site mutation. Cell, 46, 827-835.
46. Lu,X.B., Heimer,J., Rekosh,D. and Hammarskjold,M.L. (1990) U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc. Natl Acad. Sci. USA, 87, 7598-7602.
47. Gemignani,F., Sazani,P., Morcos,P. and Kole,R. (2002) Temperature-dependent splicing of beta-globin pre-mRNA. Nucleic Acids Res., 30, 4592-4598.
48. Weil,D., D'Alessio,M., Ramirez,F., Steinmann,B., Wirtz,M.K., Glanville,R.W. and Hollister,D.W. (1989) Temperature-dependent expression of a collagen splicing defect in the fibroblasts of a patient with Ehlers-Danlos syndrome type VII. J. Biol. Chem., 264, 16804-16809.
49. Hwang,D.Y. and Cohen,J.B. (1996) U1 snRNA promotes the selection of nearby 5′ splice sites by U6 snRNA in mammalian cells. Genes Dev., 10, 338-350.
50. Brackenridge,S., Wilkie,A.O. and Screaton,G.R. (2003) Efficient use of a 'dead-end' GA 5′ splice site in the human fibroblast growth factor receptor genes. EMBO J., 22, 1620-1631.
51. Liu,Z.R., Sargueil,B. and Smith,C.W. (1998) Detection of a novel ATP-dependent cross-linked protein at the 5′ splice site-U1 small nuclear RNA duplex by methylene blue-mediated photo-cross-linking. Mol. Cell. Biol., 18, 6910-6920.
52. Liu,Z.R. (2002) p68 RNA helicase is an essential human splicing factor that acts at the U1 snRNA-5′ splice site duplex. Mol. Cell. Biol., 22, 5443-5450.
53. Chen,J.Y., Stands,L., Staley,J.P., Jackups,R.R.Jr, Latus,L.J. and Chang,T.H. (2001) Specific alterations of U1-C protein or U1 small nuclear RNA can eliminate the requirement of Prp28p, an essential DEAD box splicing factor. Mol. Cell, 7, 227-232.